Clinical trial

Shiga Progression of Diabetes, Nephropathy and Retinopathy

NCT00846716

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-03-01

PhaseNA

Study timeline

Study start (unknown)2008-03-01Date precision: month

Registry last updated2009-02-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

Pioglitazone add on to SU or biguanideDRUG

SU or BiguanideDRUG

Sponsors & collaborators

Shiga Universitylead sponsor

Kanazawa Medical Universitycollaborator

Nagahama Red Cross Hospitalcollaborator

Nagahama City Hospitalcollaborator

Kohka Public Hospitalcollaborator

Second Okamoto General Hospitalcollaborator

Omihachiman COmmunity Medical Centercollaborator

Yasu Hospitalcollaborator

Toyosato Hospitalcollaborator

Ako City Hospitalcollaborator

Horide Cliniccollaborator

Kawabata Cliniccollaborator

Seta Cliniccollaborator

Shiga Cliniccollaborator

Osaka Universitycollaborator

NTT West Osaka Hospitalcollaborator

Hyogo prefectural Amagasaki Hospitalcollaborator

Tomita Cliniccollaborator

Sawada Cliniccollaborator

Social Insurance Shiga Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00846716 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.